Therapy holds promise for boosting mobility in kids with down syndrome
NCT ID NCT07653399
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a type of physical therapy called Neurodevelopmental Treatment (NDT) can help preschool children with Down syndrome improve their balance, mobility, and walking ability. Twenty children aged 3 to 6 years will receive individualized NDT sessions twice a week for 8 weeks. Researchers will measure changes in balance, walking capacity, and daily functional skills before and after the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Neurodevelopmental Treatment (NDT) based on the Bobath concept
- What this could lead to
- If effective, this therapy could offer a structured way to improve balance and mobility in young children with Down syndrome, enhancing their daily independence.
- What could go wrong
- This is a small pilot study with no control group, so results may not be generalizable. Improvements could be due to natural development or other factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Oct 2019
- Finished
-
Dec 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 to 6 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Diagnosis of Down syndrome Age between 3 and 6 years Gross Motor Function Classification System (GMFCS) Level I or II Ability to walk independently without assistive devices Ability to cooperate with assessment and treatment procedures Parent or legal guardian willing to provide informed consent Exclusion Criteria: Severe visual impairment Diagnosis of autism spectrum disorder Significant cooperation difficulties preventing participation in assessments or treatment Failure to regularly attend the physiotherapy program Lower-extremity surgery within the previous 6 months Any medical condition that would prevent safe participation in the intervention program
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Down syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tek Metod Special Education and Rehabilitation Center
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can video games or vibration boards help kids with down syndrome get stronger?
- A simple blood draw could one day detect down syndrome in pregnancy
- Could hidden blood problems be common in children with certain genetic syndromes?
- Can a simple checklist predict how well dental treatment will go for people with down syndrome?
- Eye scans could spot hidden vision risk in down syndrome
- Playtime as brain training: a new approach targets thinking skills in down syndrome